Xeloda Side Effects
Generic name: capecitabine
Note: This document contains side effect information about capecitabine. Some of the dosage forms listed on this page may not apply to the brand name Xeloda.
Some side effects of Xeloda may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to capecitabine: oral tablet
Get emergency medical help if you have any of these signs of an allergic reaction while taking capecitabine (the active ingredient contained in Xeloda) hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:
nausea, loss of appetite, eating much less than usual, vomiting (more than once in 24 hours);
severe diarrhea (more than 4 times per day, or during the night);
bloody, black, or tarry stools;
coughing up blood or vomit that looks like coffee grounds;
fever, chills, body aches, flu symptoms, easy bruising or bleeding, white patches or sores inside your mouth or on your lips;
pale skin, feeling light-headed or short of breath, rapid heart rate, trouble concentrating;
pain, tenderness, redness, swelling, blistering, or peeling skin on your hands or feet;
swelling, rapid weight gain; or
jaundice (yellowing of the skin or eyes).
Common side effects may include:
stomach pain or upset, constipation;
mild skin rash; or
numbness or tingling in your hands or feet.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to capecitabine: oral tablet
Hematologic side effects including lymphopenia (58% to 94%), anemia (44% to 74%), neutropenia (16% to 22%), and thrombocytopenia (15% to 21%) have been reported. Cases of severe hypertriglyceridemia induced by capecitabine (the active ingredient contained in Xeloda) have also been reported.
Gastrointestinal side effects including diarrhea (50%), nausea (44%), vomiting (26%), stomatitis (23%), abdominal pain (17%), constipation (9%), and dyspepsia (6%) have been reported. A case of capecitabine-induced pancreatitis has also been reported.
Dermatologic side effects including hand and foot syndrome (35% to 45%), dermatitis (23% to 31%), nail disorder (4%), alopecia, erythematous rash, pruritus, eruptive multiple lentigo maligna-like lesions, radiation recall dermatitis, pyogenic granulomas, photoeruption, hyperpigmentation, and inflammatory responses in actinic keratosis have been reported. A case of leopard-like vitiligo and a case of subacute cutaneous lupus erythematosus have also been reported.
Hepatic side effects including hyperbilirubinemia (34%) and hepatic failure have been reported.
General side effects including fatigue (34%), pyrexia (10%), and limb pain (4%) have been reported.
Metabolic side effects including anorexia (20%) and dehydration (5%) have been reported.
Nervous system side effects including paresthesia (12%), headache (7%), dizziness (5%), and insomnia (3%) have been reported. A case of cerebellar ataxia has also been reported.
Ocular side effects including eye irritation (10%) and lacrimal duct stenosis have been reported.
Cardiovascular side effects including edema (6%) have been reported. Three cases of severe angina-like chest pain possibly or probably related to capecitabine (the active ingredient contained in Xeloda) treatment have been reported. One case of capecitabine-induced coronary vasospasm has also been reported.
Musculoskeletal side effects including myalgia (4%) have been reported.
Other side effects including a case of tumor lysis syndrome have been reported.
More Xeloda resources
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.